These M2-polarized TAMs secrete anti-inflammatory and pro-tumoral factors (e.g., interleukin (IL)-10, transforming growth factor (TGF-β), vascular endothelial growth factor) and inhibit effective anti-tumor immunity, correlating with poor patient outcomes [4,5,6,7]. The gene discussed is TGFB1; the disease is neoplasm.